Durham, NC, United States of America

Jeffrey Alan Oplinger

USPTO Granted Patents = 8 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Cary, NC (US) (1999 - 2001)
  • Apex, NC (US) (2002)
  • Durham, NC (US) (2001 - 2007)

Company Filing History:


Years Active: 1999-2007

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Journey of Jeffrey Alan Oplinger

Introduction: Jeffrey Alan Oplinger, based in Durham, NC, is a prominent inventor recognized for his significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, Oplinger has played a critical role in the development of novel compounds aimed at treating various diseases and conditions.

Latest Patents: Among his latest inventions, Oplinger has developed two noteworthy patents. The first, titled "Condensed heterocyclic compounds as calcitonin agonists," focuses on novel fused heterocyclic ring system compounds and their methods for use in treatment and prevention of specific diseases. The second patent, "Substituted oxazoles and thiazoles derivatives as hPPARγ and hPPARα activators," discloses compounds that serve as dual activators of hPPARγ and hPPARα, showcasing innovative chemical structures meant for therapeutic applications.

Career Highlights: Oplinger’s career includes key positions at renowned pharmaceutical companies such as Glaxo Wellcome Inc. and GlaxoSmithKline LLC. His work has not only accrued a substantial number of patents but also has had a significant impact in the pharmaceutical industry through the development of novel therapeutic agents.

Collaborations: Throughout his career, Jeffrey has worked alongside notable colleagues like Barry George Shearer and Eric Steven Furfine. These collaborations have fostered a creative environment essential for innovation and the advancement of pharmaceutical research.

Conclusion: Jeffrey Alan Oplinger's contributions to the field of invention are marked by his innovative spirit and commitment to improving healthcare outcomes. His patents reflect a dedication to addressing complex medical challenges, solidifying his legacy as a leading figure in pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…